Asta Bio

Venture Round
astabiotx.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Venture Round
Last Announced Undisclosed
Investors 1 Backer
Decision Makers 2 Verified

About Asta Bio

Our technology combines 211-Astatine, the most druggable alpha-emitting radioisotope, with our proprietary Radiobody™ targeting molecules. This innovative approach ensures precise radiation delivery, destroying tumor cells by breaking their DNA strands without harming surrounding healthy cells.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Venture Round
Global Headquarters Undisclosed
Tracked Since Oct 11, 2026

Web & Domain Identity

Official Website astabiotx.com
Domain Registered Date Mar 27, 2024

Social & Network Presence

X / Twitter Profile @team
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Milestone

    Website domain registered

    astabiotx.com

Investors & Backers

1
IndieBio

Funding History

Venture Round · Undisclosed

Backers: IndieBio

Undisclosed Source

Founders & Leadership

2

Ahmad-Reza Saadat

Chief Executive Officer, Co-Founder

Work email & phone locked Unlock →

Rebekah O'Donnell

Chief Scientific Officer, Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts